Winton Group’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-144,058
Closed -$7.03M 1214
2018
Q2
$7.03M Buy
144,058
+86,079
+148% +$4.46M 0.18% 209
2018
Q1
$2.73M Sell
57,979
-146,119
-72% -$7.03M 0.08% 285
2017
Q4
$10.2M Buy
204,098
+99,104
+94% +$4.92M 0.29% 93
2017
Q3
$6.08M Buy
104,994
+11,289
+12% +$671K 0.19% 132
2017
Q2
$6.29M Buy
93,705
+54,400
+138% +$3.44M 0.19% 152
2017
Q1
$2.57M Buy
+39,305
New +$2.43M 0.07% 251
2015
Q1
Sell
-13,869
Closed -$997K 624
2014
Q4
$997K Buy
13,869
+1,216
+10% +$84.3K 0.01% 453
2014
Q3
$875K Buy
12,653
+3,720
+42% +$262K 0.01% 547
2014
Q2
$555K Buy
+8,933
New +$524K ﹤0.01% 589

Other funds holding LPNT

Winton Group's LPNT Position: Q3 2018 in Review

Winton Group sold out of LifePoint Health, Inc. (LPNT) in Q3 2018, closing a stake of 144,058 shares — an estimated $7.03M sold.

Winton Group first reported a position in LPNT in Q2 2014 and held it in 9 quarters. The position peaked at $10.2M in Q4 2017. 223 funds tracked by Wall St. Rank hold LPNT as of Q3 2018.

  • Winton Group reported no remaining LifePoint Health, Inc. position as of Q3 2018 after selling out during the quarter.
  • Winton Group sold 144,058 LifePoint Health, Inc. shares in Q3 2018, an estimated $7.03M.
  • Winton Group first reported a position in LifePoint Health, Inc. in Q2 2014 and held it in 9 quarters.
  • Winton Group's LifePoint Health, Inc. position peaked at $10.2M in Q4 2017.
  • 223 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q3 2018.

Based on Winton Group's 13F filing for Q3 2018, filed 2 Nov 2018.